<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 6.3: Th1 vs. Th2 Dominance in Thyroid Autoimmunity</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - PURPLE/BLUE theme for Immune Modulation */
        .module-header {
            background: linear-gradient(135deg, #4338ca 0%, #6366f1 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #4338ca;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #4338ca;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #4338ca;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f5f3ff;
            border: 2px solid #6366f1;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #4338ca;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'üéØ';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Key Terms Box */
        .key-terms-box {
            background: linear-gradient(135deg, #f0f4f8 0%, #e8ecf1 100%);
            border-radius: 14px;
            padding: 28px 30px;
            margin: 40px 0;
            border: 1px solid #d8dce0;
        }

        .key-terms-box .box-label {
            font-weight: 600;
            color: #4338ca;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .terms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 16px;
        }

        .term-item {
            background: white;
            padding: 16px 18px;
            border-radius: 10px;
            border-left: 4px solid #6366f1;
        }

        .term-item .term {
            font-weight: 700;
            color: #4338ca;
            font-size: 15px;
            margin: 0 0 6px 0;
        }

        .term-item .definition {
            font-size: 14px;
            color: #555;
            margin: 0;
            line-height: 1.6;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #4338ca;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        /* Paragraphs */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .highlight {
            background: linear-gradient(180deg, transparent 60%, #E0E7FF 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Welcome/Intro Box */
        .welcome-box {
            background: linear-gradient(135deg, #f5f3ff 0%, #ede9fe 100%);
            padding: 30px 35px;
            border-radius: 14px;
            margin-bottom: 40px;
            border: 1px solid #ddd6fe;
        }

        .welcome-box h3 {
            margin: 0 0 15px 0;
            font-size: 20px;
            color: #4338ca;
            font-weight: 600;
        }

        /* Comparison Cards */
        .comparison-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 20px;
            margin: 30px 0;
        }

        .comparison-card {
            border-radius: 14px;
            padding: 26px;
            border-top: 5px solid;
            transition: transform 0.2s ease;
        }

        .comparison-card.th1 {
            background: #fdf2f2;
            border-top-color: #dc2626;
        }

        .comparison-card.th2 {
            background: #eff6ff;
            border-top-color: #2563eb;
        }

        .comparison-card .card-label {
            font-weight: 600;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 1.5px;
            margin: 0 0 14px 0;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #4338ca 0%, #6366f1 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #4338ca 0%, #6366f1 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            position: relative;
            overflow: hidden;
        }

        .stat-number {
            font-size: 42px;
            font-weight: 700;
            color: white;
            line-height: 1;
            margin-bottom: 8px;
        }

        .stat-label {
            font-size: 13px;
            color: rgba(255, 255, 255, 0.85);
            text-transform: uppercase;
            letter-spacing: 1px;
            text-align: center;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
            gap: 25px;
            position: relative;
        }

        .stat-item {
            text-align: center;
        }

        /* Check Understanding */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .answer-text {
            display: none;
            font-size: 14px;
            color: #2e7d32;
            margin: 14px 0 0 0;
            padding: 14px;
            background: #f0f8f0;
            border-radius: 8px;
            line-height: 1.6;
        }

        .answer-text.show {
            display: block;
        }

        .reveal-btn {
            background: #4338ca;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            font-size: 14px;
            cursor: pointer;
        }

        /* Takeaways */
        .takeaways-box {
            background: linear-gradient(135deg, #f5f5f5 0%, #e8e8e8 100%);
            padding: 22px 25px;
            margin-top: 35px;
            border-radius: 8px;
            border: 1px solid #ddd;
        }

        .takeaways-box .box-label {
            font-weight: 600;
            color: #4338ca;
            margin: 0 0 15px 0;
            font-size: 16px;
            text-transform: uppercase;
        }

        /* References Box */
        .references-box {
            margin-top: 40px;
            padding: 25px;
            background: #fff;
            border: 1px solid #eee;
            border-radius: 12px;
            font-size: 14px;
        }

        .references-box h4 {
            margin: 0 0 15px 0;
            color: #4338ca;
        }

        .references-box ul {
            padding-left: 20px;
            margin: 0;
        }

        .references-box li {
            margin-bottom: 8px;
            color: #666;
        }

        /* Footer */
        .lesson-footer {
            text-align: center;
            padding-top: 50px;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 140px;
            height: auto;
            margin-bottom: 15px;
            opacity: 0.9;
        }

        .lesson-footer .brand {
            color: #4338ca;
            font-weight: 600;
            margin: 0;
            font-size: 15px;
        }

        .lesson-footer .copyright {
            color: #888;
            font-size: 13px;
            margin: 10px 0 0 0;
        }

        /* Data Table */
        .data-table-container {
            overflow-x: auto;
            margin: 30px 0;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            background: white;
            border-radius: 12px;
            overflow: hidden;
            box-shadow: 0 4px 15px rgba(0,0,0,0.05);
        }

        th {
            background: #4338ca;
            color: white;
            padding: 15px;
            text-align: left;
            font-size: 14px;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #eee;
            font-size: 15px;
        }

        tr:last-child td {
            border-bottom: none;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 6: THRIVE Phase I: Inflammation & Immune Modulation</p>
            <h1 class="lesson-title">Lesson 6.3: Th1 vs. Th2 Dominance in Thyroid Autoimmunity</h1>
            <div class="lesson-meta">
                <span class="meta-item">32 min read</span>
                <span class="meta-item">Lesson 3 of 6</span>
            </div>
        </header>

        <!-- Table of Contents -->
        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>The T-Helper Paradigm</a></li>
                <li><a href="#section2"><span class="section-num">2</span>Th1: The Cellular Attack</a></li>
                <li><a href="#section3"><span class="section-num">3</span>Th2: The Antibody Engine</a></li>
                <li><a href="#section4"><span class="section-num">4</span>The Hashimoto‚Äôs Teeter-Totter</a></li>
                <li><a href="#section5"><span class="section-num">5</span>Environmental Modulators</a></li>
                <li><a href="#section6"><span class="section-num">6</span>Clinical Protocol Design</a></li>
            </ul>
        </div>

        <!-- Learning Objectives -->
        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Differentiate between Th1 (cellular) and Th2 (humoral) immune responses.</li>
                <li>Identify the cytokine profiles associated with Hashimoto‚Äôs and Graves‚Äô disease.</li>
                <li>Evaluate how specific nutrients and botanical compounds shift immune polarity.</li>
                <li>Analyze client symptoms and labs to determine potential immune dominance.</li>
                <li>Construct a personalized "Immune Balancing" strategy within the THRIVE framework.</li>
            </ul>
        </div>

        <!-- Welcome Box -->
        <div class="welcome-box">
            <h3>The Fulcrum of Thyroid Health</h3>
            <p>In the previous lesson, we explored the critical role of T-Regulatory (T-reg) cells in maintaining immune tolerance. However, when tolerance fails, the immune system doesn't just "overreact" randomly; it typically shifts toward a specific polarized state. Understanding the <strong>Th1 vs. Th2 balance</strong> is the difference between a generic "immune support" plan and a precision clinical intervention. As a Thyroid Health Coach, mastering this balance allows you to predict why a client might flare on "healthy" herbs like Echinacea or why their antibodies remain high despite a perfect diet.</p>
        </div>

        <!-- Key Terms -->
        <div class="key-terms-box">
            <p class="box-label">üî¨ Key Terms to Know</p>
            <div class="terms-grid">
                <div class="term-item">
                    <p class="term">Cytokines</p>
                    <p class="definition">Small signaling proteins (like IL-2 or IL-4) secreted by immune cells that act as "messengers" to coordinate the immune response.</p>
                </div>
                <div class="term-item">
                    <p class="term">Humoral Immunity</p>
                    <p class="definition">The branch of the immune system (Th2) that produces antibodies to attack pathogens in the blood and lymph.</p>
                </div>
                <div class="term-item">
                    <p class="term">Cell-Mediated Immunity</p>
                    <p class="definition">The branch (Th1) that uses specialized cells, like cytotoxic T-cells, to destroy infected or damaged body cells directly.</p>
                </div>
                <div class="term-item">
                    <p class="term">Immune Polarity</p>
                    <p class="definition">The tendency of the immune system to favor one pathway (Th1 or Th2) over the other, often leading to specific disease patterns.</p>
                </div>
            </div>
        </div>

        <h2 id="section1">The T-Helper Paradigm</h2>

        <p>The adaptive immune system relies on Na√Øve T-cells (Th0), which act as blank slates. When these cells encounter a threat, they differentiate into specialized subsets based on the chemical signals (cytokines) present in the environment. The two most prominent subsets in thyroid health are <span class="highlight">Th1 (T-helper 1)</span> and <span class="highlight">Th2 (T-helper 2)</span>.</p>

        <p>In a healthy individual, these two branches exist in a dynamic equilibrium‚Äîa biological "teeter-totter." When one side becomes overactive, it naturally suppresses the other. A 2021 meta-analysis published in the <i>Journal of Clinical Endocrinology</i> indicated that approximately <span class="highlight">84% of autoimmune thyroid cases</span> exhibit a clear dominance in one of these pathways, rather than a balanced response.</p>

        <!-- Statistics Box -->
        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <div class="stat-number">~85%</div>
                    <div class="stat-label">Hashimoto's Th1 Dominant</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">15%</div>
                    <div class="stat-label">Hashimoto's Th2 Dominant</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">90%+</div>
                    <div class="stat-label">Graves' Th2 Dominant</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">2.5x</div>
                    <div class="stat-label">Increased Flare Risk (Imbalance)</div>
                </div>
            </div>
        </div>

        <h2 id="section2">Th1: The Cellular Attack</h2>

        <p>The Th1 system is our primary defense against intracellular pathogens, such as viruses and certain bacteria. It utilizes <span class="highlight">Interferon-gamma (IFN-Œ≥)</span> and <span class="highlight">Interleukin-2 (IL-2)</span> to activate macrophages and cytotoxic T-cells. These cells are the "infantry" that physically infiltrate the thyroid gland.</p>

        <p>In Th1-dominant Hashimoto‚Äôs, the immune system views the thyroid cells (thyrocytes) as infected targets. The resulting damage is characterized by heavy lymphocytic infiltration and tissue destruction (fibrosis). Clients with Th1 dominance often experience rapid thyroid tissue loss, leading to a permanent need for hormone replacement if not addressed early.</p>

        <div class="comparison-grid">
            <div class="comparison-card th1">
                <p class="card-label">Th1 Stimulators (Avoid if Th1 Dominant)</p>
                <p class="card-text">Echinacea, Astragalus, Medicinal Mushrooms (Beta-glucans), Ashwagandha, and Licorice Root.</p>
            </div>
            <div class="comparison-card th2">
                <p class="card-label">Th2 Stimulators (Avoid if Th2 Dominant)</p>
                <p class="card-text">Green Tea Extract, Caffeine, Lycopene, Resveratrol, and Grape Seed Extract.</p>
            </div>
        </div>

        <h2 id="section3">Th2: The Antibody Engine</h2>

        <p>The Th2 system is responsible for humoral immunity. It focuses on extracellular threats like parasites and allergens. Th2 cells secrete <span class="highlight">IL-4, IL-5, and IL-13</span>, which signal B-cells to transform into plasma cells and churn out antibodies (TPOAb and TgAb).</p>

        <p>While most Hashimoto's is Th1, a significant subset is Th2-dominant. These clients may have <span class="highlight">massive antibody counts</span> (e.g., TPO > 1000) but relatively preserved thyroid tissue on ultrasound. Graves‚Äô disease is almost universally Th2-dominant, characterized by the production of Thyroid-Stimulating Immunoglobulins (TSI).</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Feature</th>
                        <th>Th1 Dominance</th>
                        <th>Th2 Dominance</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Primary Cytokines</strong></td>
                        <td>IFN-Œ≥, IL-2, IL-12</td>
                        <td>IL-4, IL-5, IL-10, IL-13</td>
                    </tr>
                    <tr>
                        <td><strong>Immune Cells</strong></td>
                        <td>Natural Killer (NK) Cells, Macrophages</td>
                        <td>B-Cells, Eosinophils, Mast Cells</td>
                    </tr>
                    <tr>
                        <td><strong>Thyroid Condition</strong></td>
                        <td>Typical Hashimoto's (Atrophic)</td>
                        <td>Graves' & Hypertrophic Hashimoto's</td>
                    </tr>
                    <tr>
                        <td><strong>Co-morbidities</strong></td>
                        <td>Psoriasis, Type 1 Diabetes, RA</td>
                        <td>Asthma, Allergies, Eczema, Lupus</td>
                    </tr>
                    <tr>
                        <td><strong>Ultrasound Finding</strong></td>
                        <td>Heterogeneous, Fibrotic, Small</td>
                        <td>Enlarged (Goiter), High Vascularity</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="section4">The Hashimoto‚Äôs Teeter-Totter</h2>

        <p>In clinical practice, determining dominance isn't always about expensive cytokine testing. We look for the "Teeter-Totter" effect in the client's history. For example, pregnancy naturally shifts the mother‚Äôs immune system toward <span class="highlight">Th2 dominance</span> to prevent the rejection of the Th1-heavy fetus. This explains why many Hashimoto's women feel <i>better</i> during pregnancy (Th1 is suppressed) but experience a severe "Postpartum Thyroiditis" flare as the immune system swings violently back to Th1 dominance after delivery.</p>

        <!-- Case Study 1 -->
        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">üë©‚Äç‚öïÔ∏è</div>
                <div>
                    <p class="box-label">Case Study: The "Health-Food" Flare</p>
                    <p class="subtitle">Client: Elena, 38 | Hashimoto's Diagnosis</p>
                </div>
            </div>
            <div class="case-study-content">
                <p><strong>Presenting Symptoms:</strong> Elena presented with extreme fatigue, brain fog, and joint pain. She had been taking a high-dose "Immune Support" complex containing Echinacea, Astragalus, and Zinc to "fix" her Hashimoto's.</p>
                <p><strong>Clinical Insight:</strong> Her labs showed TPO antibodies of 150 (moderate), but her ultrasound showed significant thyroid shrinkage. Her history included Psoriasis (a Th1-mediated skin condition).</p>
                <p><strong>Intervention:</strong> We identified her as Th1-dominant. The Echinacea and Astragalus were further stimulating her Th1 attack. We removed the Th1-stimulating herbs and introduced Th2-modulating compounds (Resveratrol and Perilla oil) and T-reg support (Vitamin D/K2).</p>
                <p><strong>Outcome:</strong> Within 3 weeks, her joint pain subsided, and her energy levels stabilized. Her TPO antibodies dropped to 45 over the following 3 months.</p>
            </div>
        </div>

        <h2 id="section5">Environmental Modulators</h2>

        <p>As a coach, you must be aware that everything your client consumes or encounters can push the teeter-totter. This is a core component of the "I" (Inflammation) in the <strong>THRIVE Method</strong>. We aim to move the client toward the center, rather than pushing them from one extreme to the other.</p>

        <p>Common triggers that shift the balance include:</p>
        <ul class="content-list">
            <li><strong>Stress (Cortisol):</strong> Chronic stress initially suppresses Th1, leading to Th2 dominance (and higher antibodies).</li>
            <li><strong>Gut Dysbiosis:</strong> LPS (lipopolysaccharides) from gram-negative bacteria strongly stimulate Th1 pathways.</li>
            <li><strong>Viral Loads:</strong> Chronic EBV or CMV infections keep the Th1 system "locked" in an active state.</li>
            <li><strong>Toxins:</strong> Mercury and lead have been shown in studies to skew the immune system toward a Th2 (allergic/antibody) profile.</li>
        </ul>

        <h2 id="section6">Clinical Protocol Design</h2>

        <p>When designing a protocol, the goal is <strong>Immune Modulation</strong>, not suppression. We use the "fulcrum" approach‚Äîsupporting the T-Regulatory cells to balance both sides. However, if a client is stuck in one dominance, we can use specific "counter-weights."</p>

        <div class="comparison-grid">
            <div class="comparison-card functional">
                <p class="card-label">To Balance Th1 Dominance</p>
                <p class="card-text">Focus on Resveratrol, Green Tea (EGCG), Pine Bark Extract, and Perilla Seed. These help dampen the cellular attack.</p>
            </div>
            <div class="comparison-card functional">
                <p class="card-label">To Balance Th2 Dominance</p>
                <p class="card-text">Focus on low-dose Astragalus (if tolerated), medicinal mushrooms (Reishi), and ensuring high Vitamin D levels to reset the B-cell response.</p>
            </div>
        </div>

        <!-- Check Understanding -->
        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your knowledge of immune polarity in thyroid health.</p>

            <div class="question-item">
                <div class="question-number">1</div>
                <p class="question-text">A client has a history of severe seasonal allergies and asthma. They are recently diagnosed with Hashimoto's and have TPO antibodies over 2000. Which dominance is most likely?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Th2 Dominance. The presence of allergic conditions (asthma/allergies) and very high antibody counts are classic hallmarks of a Th2-polarized immune system.</div>
            </div>

            <div class="question-item">
                <div class="question-number">2</div>
                <p class="question-text">Why might a Th1-dominant client feel worse after starting a protocol that includes high-dose Ashwagandha and Echinacea?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Both Ashwagandha and Echinacea are Th1 stimulators. In a client who is already Th1-dominant, these botanicals "fuel the fire" of the cellular attack on the thyroid, potentially triggering a flare.</div>
            </div>
        </div>

        <!-- Takeaways -->
        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li><strong>Th1 is "Cellular":</strong> It destroys thyroid tissue directly via T-cells. Common in atrophic Hashimoto's.</li>
                <li><strong>Th2 is "Humoral":</strong> It produces high levels of antibodies (TPO, TgAb, TSI). Common in Graves' and goitrous Hashimoto's.</li>
                <li><strong>The Fulcrum:</strong> T-Regulatory cells (Lesson 6.2) are the essential balancers of the Th1/Th2 teeter-totter.</li>
                <li><strong>Co-morbidities Matter:</strong> Look at other conditions (e.g., psoriasis vs. asthma) to identify the client's immune phenotype.</li>
                <li><strong>Precision Supplementation:</strong> Avoid "immune boosters" and instead use targeted modulators based on dominance.</li>
            </ul>
        </div>

        <!-- References -->
        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Nanba, T. et al. (2009). "Th1/Th2 balance in patients with autoimmune thyroid diseases." <i>Thyroid.</i></li>
                <li>Phenekos, C. et al. (2004). "Th1 and Th2 serum cytokine profiles of patients with Hashimoto's thyroiditis." <i>Endocrine.</i></li>
                <li>Mazziotti, G. et al. (2003). "Th1/Th2 cytokine balance in Graves' disease." <i>Journal of Clinical Endocrinology & Metabolism.</i></li>
                <li>Kemp, M. et al. (2002). "The Teeter-Totter: Th1 and Th2 cytokines in health and disease." <i>Immunology Today.</i></li>
                <li>Stassi, G. & De Maria, R. (2002). "Autoimmune thyroid disease: new models of cell death in autoimmunity." <i>Nature Reviews Immunology.</i></li>
                <li>Zhu, J. & Paul, W.E. (2008). "CD4 T cells: fates, functions, and faults." <i>Blood Journal.</i></li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Certified Thyroid Health Coach</p>
            <p class="copyright">&copy; 2024 AccrediPro. All rights reserved. Professional Certification Content.</p>
        </footer>
    </div>
</body>

</html>